Personal tools

Coexpression cluster:C153: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C153_rhabdomyosarcoma_liposarcoma_pancreatic_somatostatinoma_Reticulocytes_lymphoma_testicular |id=C153 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C153_rhabdomyosarcoma_liposarcoma_pancreatic_somatostatinoma_Reticulocytes_lymphoma_testicular
|full_id=C153_rhabdomyosarcoma_liposarcoma_pancreatic_somatostatinoma_Reticulocytes_lymphoma_testicular
|gostat_on_coexpression_clusters=GO:0044428!nuclear part!0.000291093060930528!8089;57122;2636;89795;11052;4193$GO:0044446!intracellular organelle part!0.0185156016870656!8089;57122;2636;89795;11052;2620;4193$GO:0044422!organelle part!0.0185156016870656!8089;57122;2636;89795;11052;2620;4193$GO:0046619!optic placode formation involved in camera-type eye!0.0208052367719173!10818$GO:0001743!optic placode formation!0.0208052367719173!10818$GO:0048856!anatomical structure development!0.0208052367719173!8089;2660;10818;223117;2620$GO:0044453!nuclear membrane part!0.0221793827284334!57122;89795$GO:0005654!nucleoplasm!0.0221793827284334!8089;11052;4193$GO:0042382!paraspeckles!0.0221793827284334!11052$GO:0017163!negative regulator of basal transcription activity!0.0221793827284334!4193$GO:0005069!transmembrane receptor protein tyrosine kinase docking protein activity!0.0277017948375343!10818$GO:0005849!mRNA cleavage factor complex!0.0277017948375343!11052$GO:0031965!nuclear membrane!0.0277017948375343!57122;89795$GO:0005832!chaperonin-containing T-complex!0.0277017948375343!10576$GO:0031981!nuclear lumen!0.0277017948375343!8089;11052;4193$GO:0005068!transmembrane receptor protein tyrosine kinase adaptor protein activity!0.0277017948375343!10818$GO:0044424!intracellular part!0.0277017948375343!89795;11052;2620;4193;10576;8089;10818;57122;2636;56890$GO:0005634!nucleus!0.0277017948375343!8089;57122;2636;56890;89795;11052;4193$GO:0005635!nuclear envelope!0.0277017948375343!57122;89795$GO:0007185!transmembrane receptor protein tyrosine phosphatase signaling pathway!0.0277017948375343!10818$GO:0016299!regulator of G-protein signaling activity!0.0277017948375343!10818$GO:0007350!blastoderm segmentation!0.0277017948375343!10818$GO:0010092!specification of organ identity!0.0277017948375343!10818$GO:0000578!embryonic axis specification!0.0277017948375343!10818$GO:0005487!nucleocytoplasmic transporter activity!0.0277017948375343!57122$GO:0008595!determination of anterior/posterior axis, embryo!0.0277017948375343!10818$GO:0001759!induction of an organ!0.0277017948375343!10818$GO:0007351!tripartite regional subdivision!0.0277017948375343!10818$GO:0031128!induction!0.0295437981484139!10818$GO:0045168!cell-cell signaling during cell fate commitment!0.0295437981484139!10818$GO:0005066!transmembrane receptor protein tyrosine kinase signaling protein activity!0.0321594126627902!10818$GO:0009948!anterior/posterior axis specification!0.0348827170122456!10818$GO:0019211!phosphatase activator activity!0.0348827170122456!10818$GO:0005640!nuclear outer membrane!0.0348827170122456!89795$GO:0032502!developmental process!0.0348827170122456!8089;2660;10818;223117;2620$GO:0045941!positive regulation of transcription!0.0348827170122456!8089;2660$GO:0043233!organelle lumen!0.0348827170122456!8089;11052;4193$GO:0031974!membrane-enclosed lumen!0.0348827170122456!8089;11052;4193$GO:0045935!positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process!0.0359773746716329!8089;2660$GO:0048593!camera-type eye morphogenesis!0.0359773746716329!10818$GO:0007167!enzyme linked receptor protein signaling pathway!0.0370562632147988!2660;10818$GO:0009653!anatomical structure morphogenesis!0.0389763123615684!8089;10818;2620$GO:0008543!fibroblast growth factor receptor signaling pathway!0.0411705597649131!10818$GO:0007405!neuroblast proliferation!0.0417927904532598!10818$GO:0042176!regulation of protein catabolic process!0.0417927904532598!4193$GO:0009798!axis specification!0.0432822027145743!10818$GO:0005626!insoluble fraction!0.0462882495288097!4193$GO:0031325!positive regulation of cellular metabolic process!0.0462882495288097!8089;2660$GO:0006406!mRNA export from nucleus!0.0496295325094347!57122$GO:0009893!positive regulation of metabolic process!0.0498426328458537!8089;2660$GO:0005158!insulin receptor binding!0.0498426328458537!10818
|id=C153
|id=C153
}}
}}

Revision as of 17:35, 18 May 2012


Full id: C153_rhabdomyosarcoma_liposarcoma_pancreatic_somatostatinoma_Reticulocytes_lymphoma_testicular



Phase1 CAGE Peaks

Hg19::chr10:130726859..130726861,-p@chr10:130726859..130726861
-
Hg19::chr11:22688150..22688192,+p2@GAS2
Hg19::chr11:22688234..22688267,+p6@GAS2
Hg19::chr11:61310346..61310389,-p1@uc001nrw.1
Hg19::chr12:3309487..3309524,+p@chr12:3309487..3309524
+
Hg19::chr12:6069998..6070025,-p@chr12:6069998..6070025
-
Hg19::chr12:68519344..68519345,+p@chr12:68519344..68519345
+
Hg19::chr12:68542919..68542955,+p@chr12:68542919..68542955
+
Hg19::chr12:68567714..68567717,+p@chr12:68567714..68567717
+
Hg19::chr12:68570993..68570996,+p@chr12:68570993..68570996
+
Hg19::chr12:68617683..68617703,+p@chr12:68617683..68617703
+
Hg19::chr12:68696657..68696661,-p4@MDM1
Hg19::chr12:68726052..68726117,-p1@MDM1
Hg19::chr12:68726131..68726159,-p2@MDM1
Hg19::chr12:69080734..69080808,+p1@NUP107
Hg19::chr12:69106435..69106441,+p@chr12:69106435..69106441
+
Hg19::chr12:69201923..69202028,+p1@MDM2
Hg19::chr12:69234561..69234599,+p@chr12:69234561..69234599
+
Hg19::chr12:69367558..69367560,+p@chr12:69367558..69367560
+
Hg19::chr12:69418868..69418872,+p@chr12:69418868..69418872
+
Hg19::chr12:69594803..69594810,-p@chr12:69594803..69594810
-
Hg19::chr12:69609220..69609225,-p@chr12:69609220..69609225
-
Hg19::chr12:69621970..69621975,-p@chr12:69621970..69621975
-
Hg19::chr12:69633341..69633366,+p1@CPSF6
Hg19::chr12:69633372..69633390,+p2@CPSF6
Hg19::chr12:69633407..69633421,+p3@CPSF6
Hg19::chr12:69641162..69641166,+p@chr12:69641162..69641166
+
Hg19::chr12:69652342..69652353,+p17@CPSF6
Hg19::chr12:69653866..69653876,+p@chr12:69653866..69653876
+
Hg19::chr12:69659244..69659255,+p@chr12:69659244..69659255
+
Hg19::chr12:69659283..69659302,+p@chr12:69659283..69659302
+
Hg19::chr12:69659340..69659357,+p@chr12:69659340..69659357
+
Hg19::chr12:69662136..69662137,+p4@AK093765
Hg19::chr12:69665761..69665770,+p31@CPSF6
Hg19::chr12:69665801..69665808,+p55@CPSF6
Hg19::chr12:69665946..69665955,+p7@CPSF6
Hg19::chr12:69667727..69667732,+p@chr12:69667727..69667732
+
Hg19::chr12:69667739..69667749,+p@chr12:69667739..69667749
+
Hg19::chr12:69667813..69667827,+p@chr12:69667813..69667827
+
Hg19::chr12:69667906..69667909,+p@chr12:69667906..69667909
+
Hg19::chr12:69676194..69676198,+p@chr12:69676194..69676198
+
Hg19::chr12:69678255..69678259,+p1@ENST00000548895
Hg19::chr12:69753448..69753577,+p1@YEATS4
Hg19::chr12:69754026..69754035,+p@chr12:69754026..69754035
+
Hg19::chr12:69754055..69754064,+p@chr12:69754055..69754064
+
Hg19::chr12:69841002..69841005,+p@chr12:69841002..69841005
+
Hg19::chr12:69864058..69864077,-p@chr12:69864058..69864077
-
Hg19::chr12:69864149..69864222,+p1@FRS2
Hg19::chr12:69875077..69875081,+p@chr12:69875077..69875081
+
Hg19::chr12:69879976..69879979,+p@chr12:69879976..69879979
+
Hg19::chr12:69885308..69885312,+p@chr12:69885308..69885312
+
Hg19::chr12:69909563..69909567,+p@chr12:69909563..69909567
+
Hg19::chr12:69914174..69914177,+p@chr12:69914174..69914177
+
Hg19::chr12:69921143..69921147,+p@chr12:69921143..69921147
+
Hg19::chr12:69937876..69937902,+p@chr12:69937876..69937902
+
Hg19::chr12:69975438..69975442,+p@chr12:69975438..69975442
+
Hg19::chr12:69979084..69979095,-p1@MIR3913-1
Hg19::chr12:69979210..69979252,+p1@CCT2
Hg19::chr12:69979270..69979281,+p2@CCT2
Hg19::chr12:69979638..69979683,+p3@CCT2
Hg19::chr12:69980043..69980088,+p4@CCT2
Hg19::chr12:69980539..69980551,+p@chr12:69980539..69980551
+
Hg19::chr12:69981346..69981356,+p@chr12:69981346..69981356
+
Hg19::chr12:69981711..69981716,+p@chr12:69981711..69981716
+
Hg19::chr12:69981962..69982010,+p@chr12:69981962..69982010
+
Hg19::chr12:69983331..69983347,+p8@CCT2
Hg19::chr12:69987281..69987295,+p@chr12:69987281..69987295
+
Hg19::chr12:69987298..69987312,+p@chr12:69987298..69987312
+
Hg19::chr12:69996323..69996329,+p@chr12:69996323..69996329
+
Hg19::chr12:69996460..69996463,+p@chr12:69996460..69996463
+
Hg19::chr12:70000134..70000135,-p@chr12:70000134..70000135
-
Hg19::chr12:70008447..70008458,+p@chr12:70008447..70008458
+
Hg19::chr12:70013307..70013310,+p@chr12:70013307..70013310
+
Hg19::chr12:70383686..70383688,+p@chr12:70383686..70383688
+
Hg19::chr12:70389117..70389122,+p@chr12:70389117..70389122
+
Hg19::chr12:70389143..70389146,+p@chr12:70389143..70389146
+
Hg19::chr12:70391649..70391654,+p@chr12:70391649..70391654
+
Hg19::chr12:78224657..78224661,+p42@NAV3
Hg19::chr12:78224667..78224680,+p5@NAV3
Hg19::chr12:80980430..80980454,+p@chr12:80980430..80980454
+
Hg19::chr13:31437561..31437585,+p@chr13:31437561..31437585
+
Hg19::chr16:7137754..7137799,+p@chr16:7137754..7137799
+
Hg19::chr19:50993024..50993039,-p@chr19:50993024..50993039
-
Hg19::chr1:188791348..188791353,-p@chr1:188791348..188791353
-
Hg19::chr1:188791367..188791376,-p@chr1:188791367..188791376
-
Hg19::chr22:46420766..46420774,+p@chr22:46420766..46420774
+
Hg19::chr2:144238354..144238358,-p1@ENST00000549032
p1@ENST00000550516
Hg19::chr2:144291788..144291791,+p@chr2:144291788..144291791
+
Hg19::chr2:144551351..144551352,-p@chr2:144551351..144551352
-
Hg19::chr2:144661193..144661223,-p@chr2:144661193..144661223
-
Hg19::chr2:155831065..155831074,+p@chr2:155831065..155831074
+
Hg19::chr2:156009264..156009270,-p@chr2:156009264..156009270
-
Hg19::chr2:190927424..190927436,-p2@MSTN
Hg19::chr2:190927447..190927466,-p1@MSTN
Hg19::chr3:106909444..106909465,-p@chr3:106909444..106909465
-
Hg19::chr3:587825..587862,+p@chr3:587825..587862
+
Hg19::chr3:587869..587880,+p@chr3:587869..587880
+
Hg19::chr4:138289924..138289941,-p@chr4:138289924..138289941
-
Hg19::chr4:138290008..138290015,-p@chr4:138290008..138290015
-
Hg19::chr5:103638280..103638288,+p@chr5:103638280..103638288
+
Hg19::chr5:73209060..73209067,-p@chr5:73209060..73209067
-
Hg19::chr6:113168012..113168027,-p@chr6:113168012..113168027
-
Hg19::chr6:113433185..113433188,-p@chr6:113433185..113433188
-
Hg19::chr6:23609145..23609162,-p@chr6:23609145..23609162
-
Hg19::chr7:150864780..150864785,-p1@GBX1
Hg19::chr7:84816235..84816246,-p7@SEMA3D
Hg19::chr7:84816288..84816301,-p3@SEMA3D
Hg19::chr7:84816323..84816334,-p6@SEMA3D
Hg19::chr7:84816338..84816354,-p5@SEMA3D
Hg19::chr7:84816355..84816384,-p2@SEMA3D
Hg19::chr7:85221253..85221277,+p@chr7:85221253..85221277
+
Hg19::chr9:9967081..9967122,-p@chr9:9967081..9967122
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0044428nuclear part0.000291093060930528
GO:0044446intracellular organelle part0.0185156016870656
GO:0044422organelle part0.0185156016870656
GO:0046619optic placode formation involved in camera-type eye0.0208052367719173
GO:0001743optic placode formation0.0208052367719173
GO:0048856anatomical structure development0.0208052367719173
GO:0044453nuclear membrane part0.0221793827284334
GO:0005654nucleoplasm0.0221793827284334
GO:0042382paraspeckles0.0221793827284334
GO:0017163negative regulator of basal transcription activity0.0221793827284334
GO:0005069transmembrane receptor protein tyrosine kinase docking protein activity0.0277017948375343
GO:0005849mRNA cleavage factor complex0.0277017948375343
GO:0031965nuclear membrane0.0277017948375343
GO:0005832chaperonin-containing T-complex0.0277017948375343
GO:0031981nuclear lumen0.0277017948375343
GO:0005068transmembrane receptor protein tyrosine kinase adaptor protein activity0.0277017948375343
GO:0044424intracellular part0.0277017948375343
GO:0005634nucleus0.0277017948375343
GO:0005635nuclear envelope0.0277017948375343
GO:0007185transmembrane receptor protein tyrosine phosphatase signaling pathway0.0277017948375343
GO:0016299regulator of G-protein signaling activity0.0277017948375343
GO:0007350blastoderm segmentation0.0277017948375343
GO:0010092specification of organ identity0.0277017948375343
GO:0000578embryonic axis specification0.0277017948375343
GO:0005487nucleocytoplasmic transporter activity0.0277017948375343
GO:0008595determination of anterior/posterior axis, embryo0.0277017948375343
GO:0001759induction of an organ0.0277017948375343
GO:0007351tripartite regional subdivision0.0277017948375343
GO:0031128induction0.0295437981484139
GO:0045168cell-cell signaling during cell fate commitment0.0295437981484139
GO:0005066transmembrane receptor protein tyrosine kinase signaling protein activity0.0321594126627902
GO:0009948anterior/posterior axis specification0.0348827170122456
GO:0019211phosphatase activator activity0.0348827170122456
GO:0005640nuclear outer membrane0.0348827170122456
GO:0032502developmental process0.0348827170122456
GO:0045941positive regulation of transcription0.0348827170122456
GO:0043233organelle lumen0.0348827170122456
GO:0031974membrane-enclosed lumen0.0348827170122456
GO:0045935positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process0.0359773746716329
GO:0048593camera-type eye morphogenesis0.0359773746716329
GO:0007167enzyme linked receptor protein signaling pathway0.0370562632147988
GO:0009653anatomical structure morphogenesis0.0389763123615684
GO:0008543fibroblast growth factor receptor signaling pathway0.0411705597649131
GO:0007405neuroblast proliferation0.0417927904532598
GO:0042176regulation of protein catabolic process0.0417927904532598
GO:0009798axis specification0.0432822027145743
GO:0005626insoluble fraction0.0462882495288097
GO:0031325positive regulation of cellular metabolic process0.0462882495288097
GO:0006406mRNA export from nucleus0.0496295325094347
GO:0009893positive regulation of metabolic process0.0498426328458537
GO:0005158insulin receptor binding0.0498426328458537



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C153&oldid=1702489"